منابع مشابه
Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis
The primary aim of the study was to evaluate the long-term effectiveness of adalimumab (ADA) in a cohort of non-radiographic axial spondyloarthritis (nr-axSpA), and the secondary aims were to identify predictive factors of response and evaluate radiological progression.We evaluated 37 patients (male/female: 12/25; mean age 49 ± 14; mean disease duration: 6.3 ± 5.8) with active nr-axSpA (Assessm...
متن کاملExtra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis.
OBJECTIVE Although the prevalence of peripheral and extra-articular disease in ankylosing spondylitis (AS) has been assessed in many studies, data on non-radiographic axial spondyloarthritis (nr-axSpA) is scanty. The aim of this study was first, to compare radiographic-axSpA/AS (r-axSpA/AS) and nr-axSpA concerning peripheral arthritis and extra-articular manifestations (EAMs), and second, to as...
متن کاملRadiographic axial spondyloarthritis versus ankylosing spondylitis.
Sirs, Braun et al. in their letter claim that in clinical practice there is no need to differentiate between a diagnosis of ‘radiographic axial spondylaorthritis (axSpA)’ and ‘non-radiographic axSpA (nr-axSpA) (1). Implicit in their reasoning is the view that nr-axSpA and AS represent one single entity, even though differences between the two entities have been reported, including gender, HLA-B...
متن کاملBurden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational study.
OBJECTIVES To assess the impact of non-radiographic axial spondyloarthritis (nr-axSpA) on patients and society based on real-world evidence from the Adelphi nr-axSpA Disease Specific Programme, a cross-sectional survey of rheumatologists and their patients in Germany, France, Spain, Italy and the UK. METHODS Physicians completed patient record forms for the next two patients consulting with n...
متن کاملEfficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis.
Anti-tumour necrosis factor (TNF) agents are recommended as second-line therapy for patients with axial spondyloarthropathies. This analysis reviewed data on studies investigating the efficacy and tolerability of anti-TNF agents in patients with non-radiographic axial spondyloarthritis (nr-axSpA) who had failed first-line non-steroidal anti-inflammatory (NSAID) treatment. Efficacy data from RCT...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Rheumatology
سال: 2015
ISSN: 0973-3698
DOI: 10.1016/j.injr.2015.07.001